The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways
Endometrial cancer (EC) is the 2nd common cancer in females after breast cancer. Besides,
it's the most common among gynecological cancers. Several epigenetic factors such as …
it's the most common among gynecological cancers. Several epigenetic factors such as …
The molecular landscape of head and neck cancer
CR Leemans, PJF Snijders, RH Brakenhoff - Nature Reviews Cancer, 2018 - nature.com
Head and neck squamous cell carcinomas (HNSCCs) arise in the mucosal linings of the
upper aerodigestive tract and are unexpectedly heterogeneous in nature. Classical risk …
upper aerodigestive tract and are unexpectedly heterogeneous in nature. Classical risk …
[HTML][HTML] Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer
H Chen, J Yao, R Bao, Y Dong, T Zhang, Y Du… - Molecular cancer, 2021 - Springer
Background The four major RNA adenosine modifications, ie, m 6 A, m 1 A, alternative
polyadenylation, and adenosine-to-inosine RNA editing, are mediated mostly by the “writer” …
polyadenylation, and adenosine-to-inosine RNA editing, are mediated mostly by the “writer” …
[HTML][HTML] Histone deacetylase inhibitors as anticancer drugs
T Eckschlager, J Plch, M Stiborova… - International journal of …, 2017 - mdpi.com
Carcinogenesis cannot be explained only by genetic alterations, but also involves
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …
[HTML][HTML] New insights into the mechanism of action of soluble klotho
GD Dalton, J Xie, SW An, CL Huang - Frontiers in endocrinology, 2017 - frontiersin.org
The klotho gene encodes a type I single-pass transmembrane protein that contains a large
extracellular domain, a membrane spanning segment, and a short intracellular domain …
extracellular domain, a membrane spanning segment, and a short intracellular domain …
Oncogenic roles and inhibitors of DNMT1, DNMT3A, and DNMT3B in acute myeloid leukaemia
Epigenetic alteration has been proposed to give rise to numerous classic hallmarks of
cancer. Impaired DNA methylation plays a central role in the onset and progression of …
cancer. Impaired DNA methylation plays a central role in the onset and progression of …
[HTML][HTML] Natural bioactive compounds targeting epigenetic pathways in cancer: a review on alkaloids, terpenoids, quinones, and isothiocyanates
N El Omari, S Bakrim, M Bakha, JM Lorenzo… - Nutrients, 2021 - mdpi.com
Cancer is one of the most complex and systemic diseases affecting the health of mankind,
causing major deaths with a significant increase. This pathology is caused by several risk …
causing major deaths with a significant increase. This pathology is caused by several risk …
[HTML][HTML] miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway
Z Wang, TE Li, M Chen, JJ Pan, KW Shen - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
Objectives: Breast cancer has been the second most prevalent and fatal malignancy due to
its frequent metastasis to other organs. We aim to study the effects of a key miRNA-mRNA …
its frequent metastasis to other organs. We aim to study the effects of a key miRNA-mRNA …
Role of histone methylation in skin cancers: Histone methylation–modifying enzymes as a new class of targets for skin cancer treatment
NC Sutopo, JH Kim, JY Cho - Biochimica et Biophysica Acta (BBA)-Reviews …, 2023 - Elsevier
Histone methylation, one of the most prominent epigenetic modifications, plays a vital role in
gene transcription, and aberrant histone methylation levels cause tumorigenesis. Histone …
gene transcription, and aberrant histone methylation levels cause tumorigenesis. Histone …
Transforming growth factor‐β, matrix metalloproteinases, and urokinase‐type plasminogen activator interaction in the cancer epithelial to mesenchymal transition
Transforming growth factor‐β (TGF‐β) is a pleiotropic factor that acts as a tumor suppressor
in the early stages, while it exerts tumor promoting activities in advanced stages of cancer …
in the early stages, while it exerts tumor promoting activities in advanced stages of cancer …